Firenze Biobank
Evaluation of Abbott Anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA Assays In a Clinical Lab Background: We evaluated the take a look at efficiency specializing in specificity of a totally automated Abbott Architect Continue reading
Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3 Human parechovirus kind 3 (HPeV3) is an etiologic agent of respiratory illnesses, meningitis, and sepsis-like sickness in each infants Continue reading
Diagnostic Potential of an IgE-ELISA in Detecting Strongyloidiasis Strongyloides stercoralisinfection is prevalent worldwide and can cause lifelong infection in immunocompetent individuals, and potentially death in immunosuppressed patients. The diagnosis is hindered Continue reading
Comparison of Commercial ELISA Kits to Confirm the Absence of Transmission in Malaria Elimination Settings Background: Antimalarial antibody measurements are useful because they reflect historical and recent exposure to malaria. As such, Continue reading
Evaluation of three commercially accessible ELISA kits for the determination of chromogranin A Chromogranin A (CgA) is presently the Most worthy tumor biomarker for diagnostic work-up, administration and follow-up of neuro-endocrine tumors Continue reading
Serological Study of Fascioliasis Using Indirect ELISA in Gorgan City, Golestan Province, Northern Iran Background: Fascioliasis is a uncared for zoonotic illness, attributable to Fasciola species in human and livestock. We aimed to detect Continue reading